Muscle Pharm Corporation (MSLPQ)

[rjanderson383]

fellow short

Where do you get this evaluation method? lol

Please do an evaluation on these 2 companies for me below
1. Revenue 78 million. net loss 10 million.

2. Revenue 78 million net gain 10 million

your evaluation method would come up with the same number.... whatever method you're using is completely worthless.

$80 million in sales, industry multiple of 1 times sales stock price of $14 plus...300% revenue growth ups that multiple to a $15 to $20 stock price on Nasdaq very soon.Floats to small to game this stock imho.


(B) Series B, Preferred Stock (Related Parties)
In August 2011, the Company issued an aggregate 51 shares of Series B Preferred Stock to two of its officers and directors. The Company accounted for the share issuance at par value since there was no future economic value that could be associated with the issuance.

This class of stock has the following provisions:
· Voting rights entitling the holders to an aggregate 51% voting control;
· Initially no rights to dividends;
· Stated value of $0.001 per share;
· Liquidation rights entitle the receipt of net assets on a pro-rata basis; and
· Non-convertible.